March 12 (Reuters) - Indivior Pharmaceuticals, Inc INDV.O:
INDIVIOR ANNOUNCES PROPOSED CONVERTIBLE SENIOR NOTES OFFERING
INDIVIOR PHARMACEUTICALS, INC - ANNOUNCES INTENTION TO OFFER $400 MILLION CONVERTIBLE SENIOR NOTES DUE 2031
INDIVIOR PHARMACEUTICALS, INC - TO USE UP TO $75 MILLION NET PROCEEDS TO REPURCHASE COMMON STOCK
INDIVIOR PHARMACEUTICALS, INC - TO USE $239 MILLION NET PROCEEDS AND $102 MILLION CASH TO REPAY BORROWINGS